Ruxience (rituximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is a CD20-directed cytolytic antibody used for a variety of lymphomas leukemias and inflammatory conditions. Although Ruxience may be used to treat cancer it is not chemotherapy.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.